The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Next-Generation Biomanufacturing Market Research Report 2024
Synopsis
The rapid maturity of the biopharmaceutical industry shows the growing importance of biomanufacturing as the most basic process for developing and manufacturing bio-based products. With the development of commercialization of biopharmaceuticals and the increase of more products in the development pipeline, biopharmaceutical companies look forward to adopting novel biomanufacturing strategies, focusing on balancing process design, performance and efficiency innovation with speed and cost.
The global Next-Generation Biomanufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Next-Generation Biomanufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next-Generation Biomanufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Next-Generation Biomanufacturing in Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Next-Generation Biomanufacturing include Merck, Thermo Fisher Scientific, Danaher, Eppendorf, Sartorius, GEA Group, bbi-biotech, Esco Group of Companies and Solaris Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Biomanufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Biomanufacturing.
Report Scope
The Next-Generation Biomanufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next-Generation Biomanufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-Generation Biomanufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Thermo Fisher Scientific
Danaher
Eppendorf
Sartorius
GEA Group
bbi-biotech
Esco Group of Companies
Solaris Biotechnology
PBS Biotech
Applikon Biotechnology
Meissner Filtration Products
Shanghai Bailun Biotechnology
Segment by Type
Upstream Biomanufacturing
Downstream Biomanufacturing
Segment by Application
Biopharmaceutical Companies
CMOs/CDMOs
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-Generation Biomanufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The rapid maturity of the biopharmaceutical industry shows the growing importance of biomanufacturing as the most basic process for developing and manufacturing bio-based products. With the development of commercialization of biopharmaceuticals and the increase of more products in the development pipeline, biopharmaceutical companies look forward to adopting novel biomanufacturing strategies, focusing on balancing process design, performance and efficiency innovation with speed and cost.
The global Next-Generation Biomanufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Next-Generation Biomanufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next-Generation Biomanufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Next-Generation Biomanufacturing in Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Next-Generation Biomanufacturing include Merck, Thermo Fisher Scientific, Danaher, Eppendorf, Sartorius, GEA Group, bbi-biotech, Esco Group of Companies and Solaris Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Biomanufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Biomanufacturing.
Report Scope
The Next-Generation Biomanufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next-Generation Biomanufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-Generation Biomanufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Thermo Fisher Scientific
Danaher
Eppendorf
Sartorius
GEA Group
bbi-biotech
Esco Group of Companies
Solaris Biotechnology
PBS Biotech
Applikon Biotechnology
Meissner Filtration Products
Shanghai Bailun Biotechnology
Segment by Type
Upstream Biomanufacturing
Downstream Biomanufacturing
Segment by Application
Biopharmaceutical Companies
CMOs/CDMOs
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-Generation Biomanufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Biomanufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Upstream Biomanufacturing
1.2.3 Downstream Biomanufacturing
1.3 Market by Application
1.3.1 Global Next-Generation Biomanufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 CMOs/CDMOs
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Biomanufacturing Market Perspective (2019-2030)
2.2 Next-Generation Biomanufacturing Growth Trends by Region
2.2.1 Global Next-Generation Biomanufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next-Generation Biomanufacturing Historic Market Size by Region (2019-2024)
2.2.3 Next-Generation Biomanufacturing Forecasted Market Size by Region (2025-2030)
2.3 Next-Generation Biomanufacturing Market Dynamics
2.3.1 Next-Generation Biomanufacturing Industry Trends
2.3.2 Next-Generation Biomanufacturing Market Drivers
2.3.3 Next-Generation Biomanufacturing Market Challenges
2.3.4 Next-Generation Biomanufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Biomanufacturing Players by Revenue
3.1.1 Global Top Next-Generation Biomanufacturing Players by Revenue (2019-2024)
3.1.2 Global Next-Generation Biomanufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Next-Generation Biomanufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next-Generation Biomanufacturing Revenue
3.4 Global Next-Generation Biomanufacturing Market Concentration Ratio
3.4.1 Global Next-Generation Biomanufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Biomanufacturing Revenue in 2023
3.5 Next-Generation Biomanufacturing Key Players Head office and Area Served
3.6 Key Players Next-Generation Biomanufacturing Product Solution and Service
3.7 Date of Enter into Next-Generation Biomanufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Biomanufacturing Breakdown Data by Type
4.1 Global Next-Generation Biomanufacturing Historic Market Size by Type (2019-2024)
4.2 Global Next-Generation Biomanufacturing Forecasted Market Size by Type (2025-2030)
5 Next-Generation Biomanufacturing Breakdown Data by Application
5.1 Global Next-Generation Biomanufacturing Historic Market Size by Application (2019-2024)
5.2 Global Next-Generation Biomanufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Next-Generation Biomanufacturing Market Size (2019-2030)
6.2 North America Next-Generation Biomanufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next-Generation Biomanufacturing Market Size by Country (2019-2024)
6.4 North America Next-Generation Biomanufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-Generation Biomanufacturing Market Size (2019-2030)
7.2 Europe Next-Generation Biomanufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next-Generation Biomanufacturing Market Size by Country (2019-2024)
7.4 Europe Next-Generation Biomanufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Biomanufacturing Market Size (2019-2030)
8.2 Asia-Pacific Next-Generation Biomanufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next-Generation Biomanufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Next-Generation Biomanufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next-Generation Biomanufacturing Market Size (2019-2030)
9.2 Latin America Next-Generation Biomanufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next-Generation Biomanufacturing Market Size by Country (2019-2024)
9.4 Latin America Next-Generation Biomanufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Biomanufacturing Market Size (2019-2030)
10.2 Middle East & Africa Next-Generation Biomanufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next-Generation Biomanufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Next-Generation Biomanufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Next-Generation Biomanufacturing Introduction
11.1.4 Merck Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next-Generation Biomanufacturing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher Next-Generation Biomanufacturing Introduction
11.3.4 Danaher Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.3.5 Danaher Recent Development
11.4 Eppendorf
11.4.1 Eppendorf Company Detail
11.4.2 Eppendorf Business Overview
11.4.3 Eppendorf Next-Generation Biomanufacturing Introduction
11.4.4 Eppendorf Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.4.5 Eppendorf Recent Development
11.5 Sartorius
11.5.1 Sartorius Company Detail
11.5.2 Sartorius Business Overview
11.5.3 Sartorius Next-Generation Biomanufacturing Introduction
11.5.4 Sartorius Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.5.5 Sartorius Recent Development
11.6 GEA Group
11.6.1 GEA Group Company Detail
11.6.2 GEA Group Business Overview
11.6.3 GEA Group Next-Generation Biomanufacturing Introduction
11.6.4 GEA Group Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.6.5 GEA Group Recent Development
11.7 bbi-biotech
11.7.1 bbi-biotech Company Detail
11.7.2 bbi-biotech Business Overview
11.7.3 bbi-biotech Next-Generation Biomanufacturing Introduction
11.7.4 bbi-biotech Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.7.5 bbi-biotech Recent Development
11.8 Esco Group of Companies
11.8.1 Esco Group of Companies Company Detail
11.8.2 Esco Group of Companies Business Overview
11.8.3 Esco Group of Companies Next-Generation Biomanufacturing Introduction
11.8.4 Esco Group of Companies Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.8.5 Esco Group of Companies Recent Development
11.9 Solaris Biotechnology
11.9.1 Solaris Biotechnology Company Detail
11.9.2 Solaris Biotechnology Business Overview
11.9.3 Solaris Biotechnology Next-Generation Biomanufacturing Introduction
11.9.4 Solaris Biotechnology Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.9.5 Solaris Biotechnology Recent Development
11.10 PBS Biotech
11.10.1 PBS Biotech Company Detail
11.10.2 PBS Biotech Business Overview
11.10.3 PBS Biotech Next-Generation Biomanufacturing Introduction
11.10.4 PBS Biotech Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.10.5 PBS Biotech Recent Development
11.11 Applikon Biotechnology
11.11.1 Applikon Biotechnology Company Detail
11.11.2 Applikon Biotechnology Business Overview
11.11.3 Applikon Biotechnology Next-Generation Biomanufacturing Introduction
11.11.4 Applikon Biotechnology Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.11.5 Applikon Biotechnology Recent Development
11.12 Meissner Filtration Products
11.12.1 Meissner Filtration Products Company Detail
11.12.2 Meissner Filtration Products Business Overview
11.12.3 Meissner Filtration Products Next-Generation Biomanufacturing Introduction
11.12.4 Meissner Filtration Products Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.12.5 Meissner Filtration Products Recent Development
11.13 Shanghai Bailun Biotechnology
11.13.1 Shanghai Bailun Biotechnology Company Detail
11.13.2 Shanghai Bailun Biotechnology Business Overview
11.13.3 Shanghai Bailun Biotechnology Next-Generation Biomanufacturing Introduction
11.13.4 Shanghai Bailun Biotechnology Revenue in Next-Generation Biomanufacturing Business (2019-2024)
11.13.5 Shanghai Bailun Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Next-Generation Biomanufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Upstream Biomanufacturing
Table 3. Key Players of Downstream Biomanufacturing
Table 4. Global Next-Generation Biomanufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Next-Generation Biomanufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Next-Generation Biomanufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Next-Generation Biomanufacturing Market Share by Region (2019-2024)
Table 8. Global Next-Generation Biomanufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Next-Generation Biomanufacturing Market Share by Region (2025-2030)
Table 10. Next-Generation Biomanufacturing Market Trends
Table 11. Next-Generation Biomanufacturing Market Drivers
Table 12. Next-Generation Biomanufacturing Market Challenges
Table 13. Next-Generation Biomanufacturing Market Restraints
Table 14. Global Next-Generation Biomanufacturing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Next-Generation Biomanufacturing Market Share by Players (2019-2024)
Table 16. Global Top Next-Generation Biomanufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Biomanufacturing as of 2023)
Table 17. Ranking of Global Top Next-Generation Biomanufacturing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Next-Generation Biomanufacturing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Next-Generation Biomanufacturing Product Solution and Service
Table 21. Date of Enter into Next-Generation Biomanufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Next-Generation Biomanufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Next-Generation Biomanufacturing Revenue Market Share by Type (2019-2024)
Table 25. Global Next-Generation Biomanufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Next-Generation Biomanufacturing Revenue Market Share by Type (2025-2030)
Table 27. Global Next-Generation Biomanufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Next-Generation Biomanufacturing Revenue Market Share by Application (2019-2024)
Table 29. Global Next-Generation Biomanufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Next-Generation Biomanufacturing Revenue Market Share by Application (2025-2030)
Table 31. North America Next-Generation Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Next-Generation Biomanufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Next-Generation Biomanufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Next-Generation Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Next-Generation Biomanufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Next-Generation Biomanufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Next-Generation Biomanufacturing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Next-Generation Biomanufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Next-Generation Biomanufacturing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Next-Generation Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Next-Generation Biomanufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Next-Generation Biomanufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Next-Generation Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Next-Generation Biomanufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Next-Generation Biomanufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Next-Generation Biomanufacturing Product
Table 49. Merck Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Next-Generation Biomanufacturing Product
Table 54. Thermo Fisher Scientific Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Danaher Company Detail
Table 57. Danaher Business Overview
Table 58. Danaher Next-Generation Biomanufacturing Product
Table 59. Danaher Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 60. Danaher Recent Development
Table 61. Eppendorf Company Detail
Table 62. Eppendorf Business Overview
Table 63. Eppendorf Next-Generation Biomanufacturing Product
Table 64. Eppendorf Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 65. Eppendorf Recent Development
Table 66. Sartorius Company Detail
Table 67. Sartorius Business Overview
Table 68. Sartorius Next-Generation Biomanufacturing Product
Table 69. Sartorius Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 70. Sartorius Recent Development
Table 71. GEA Group Company Detail
Table 72. GEA Group Business Overview
Table 73. GEA Group Next-Generation Biomanufacturing Product
Table 74. GEA Group Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 75. GEA Group Recent Development
Table 76. bbi-biotech Company Detail
Table 77. bbi-biotech Business Overview
Table 78. bbi-biotech Next-Generation Biomanufacturing Product
Table 79. bbi-biotech Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 80. bbi-biotech Recent Development
Table 81. Esco Group of Companies Company Detail
Table 82. Esco Group of Companies Business Overview
Table 83. Esco Group of Companies Next-Generation Biomanufacturing Product
Table 84. Esco Group of Companies Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 85. Esco Group of Companies Recent Development
Table 86. Solaris Biotechnology Company Detail
Table 87. Solaris Biotechnology Business Overview
Table 88. Solaris Biotechnology Next-Generation Biomanufacturing Product
Table 89. Solaris Biotechnology Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 90. Solaris Biotechnology Recent Development
Table 91. PBS Biotech Company Detail
Table 92. PBS Biotech Business Overview
Table 93. PBS Biotech Next-Generation Biomanufacturing Product
Table 94. PBS Biotech Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 95. PBS Biotech Recent Development
Table 96. Applikon Biotechnology Company Detail
Table 97. Applikon Biotechnology Business Overview
Table 98. Applikon Biotechnology Next-Generation Biomanufacturing Product
Table 99. Applikon Biotechnology Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 100. Applikon Biotechnology Recent Development
Table 101. Meissner Filtration Products Company Detail
Table 102. Meissner Filtration Products Business Overview
Table 103. Meissner Filtration Products Next-Generation Biomanufacturing Product
Table 104. Meissner Filtration Products Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 105. Meissner Filtration Products Recent Development
Table 106. Shanghai Bailun Biotechnology Company Detail
Table 107. Shanghai Bailun Biotechnology Business Overview
Table 108. Shanghai Bailun Biotechnology Next-Generation Biomanufacturing Product
Table 109. Shanghai Bailun Biotechnology Revenue in Next-Generation Biomanufacturing Business (2019-2024) & (US$ Million)
Table 110. Shanghai Bailun Biotechnology Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next-Generation Biomanufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Next-Generation Biomanufacturing Market Share by Type: 2023 VS 2030
Figure 3. Upstream Biomanufacturing Features
Figure 4. Downstream Biomanufacturing Features
Figure 5. Global Next-Generation Biomanufacturing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Next-Generation Biomanufacturing Market Share by Application: 2023 VS 2030
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. CMOs/CDMOs Case Studies
Figure 9. Research Institutions Case Studies
Figure 10. Next-Generation Biomanufacturing Report Years Considered
Figure 11. Global Next-Generation Biomanufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Next-Generation Biomanufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Next-Generation Biomanufacturing Market Share by Region: 2023 VS 2030
Figure 14. Global Next-Generation Biomanufacturing Market Share by Players in 2023
Figure 15. Global Top Next-Generation Biomanufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Biomanufacturing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Next-Generation Biomanufacturing Revenue in 2023
Figure 17. North America Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Next-Generation Biomanufacturing Market Share by Country (2019-2030)
Figure 19. United States Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Next-Generation Biomanufacturing Market Share by Country (2019-2030)
Figure 23. Germany Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Next-Generation Biomanufacturing Market Share by Region (2019-2030)
Figure 31. China Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Next-Generation Biomanufacturing Market Share by Country (2019-2030)
Figure 39. Mexico Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Next-Generation Biomanufacturing Market Share by Country (2019-2030)
Figure 43. Turkey Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Next-Generation Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 47. Danaher Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 48. Eppendorf Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 49. Sartorius Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 50. GEA Group Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 51. bbi-biotech Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 52. Esco Group of Companies Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 53. Solaris Biotechnology Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 54. PBS Biotech Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 55. Applikon Biotechnology Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 56. Meissner Filtration Products Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 57. Shanghai Bailun Biotechnology Revenue Growth Rate in Next-Generation Biomanufacturing Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
